Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
03/09/2026 24:45
BRIEF-Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co Sept 3 (Reuters) -
GENETIC SIGNATURES - REQUESTED BCAL DIAGNOSTICS TO CLARIFY DETAILS OF ITS SHAREHOLDINGS AND ASSOCIATES IN GSS
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures